Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
T2 Biosystems, Inc. (TTOO)  
$0.17 0.00 (0.00%) as of 4:30 Thu 10/12


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 16,340,000
Market Cap: 2.84(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.0623 - $0.5911
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   T2 Biosystems is an in vitro diagnostics company and engaged in the detection of sepsis-causing pathogens and antibiotic resistance genes. Co.'s products include: T2Dx® Instrument, which runs diagnostic tests from patient samples; T2Candida® Panel, which is a direct-from-blood test that identifies the lethal form of blood stream infections that cause sepsis candidemia; T2Bacteria® Panel, which is a direct-from-blood test that detects bacterial pathogens associated with sepsis; T2Resistance® Panel, which is a direct-from-blood test that detects resistance genes from both gram-positive and gram-negative pathogens; and T2SARS-CoV-2™ Panel, which detect SARS-CoV-2, the coronavirus in patients.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 48,345,798 48,364,599
Total Sell Value $0 $0 $12,851,221 $12,864,540
Total People Sold 0 0 1 5
Total Sell Transactions 0 0 8 18
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 350
  Page 7 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Sprague John M Chief Financial Officer   •       –      –    2020-02-24 4 S $0.82 $3,416 D/D (4,166) 22,222 -70%     
   Lowery Thomas J. Chief Scientific Officer   •       –      –    2020-02-24 4 AS $0.82 $4,763 D/D (5,808) 68,994 70%     
   Barclay Alec SVP, Operations   •       –      –    2020-02-24 4 AS $0.82 $4,763 D/D (5,808) 46,294 70%     
   Gibbs Michael Terrence General Counsel   •       –      –    2020-02-24 4 AS $0.82 $4,763 D/D (5,808) 60,779 70%     
   Sprague John M Chief Financial Officer   •       –      –    2020-02-21 4 OE $0.00 $0 D/D 10,000 26,388     -
   Lowery Thomas J. Chief Scientific Officer   •       –      –    2020-02-21 4 OE $0.00 $0 D/D 10,000 74,802     -
   Barclay Alec SVP, Operations   •       –      –    2020-02-21 4 OE $0.00 $0 D/D 10,000 52,102     -
   Gibbs Michael Terrence General Counsel   •       –      –    2020-02-21 4 OE $0.00 $0 D/D 10,000 66,587     -
   Lowery Thomas J. Chief Scientific Officer   •       –      –    2020-02-11 4 AS $0.77 $2,464 D/D (3,200) 64,802 55%     
   Gibbs Michael Terrence General Counsel   •       –      –    2020-02-11 4 AS $0.77 $2,464 D/D (3,200) 56,587 55%     
   Lowery Thomas J. Chief Scientific Officer   •       –      –    2020-02-09 4 OE $0.00 $0 D/D 5,833 68,002     -
   Gibbs Michael Terrence General Counsel   •       –      –    2020-02-09 4 OE $0.00 $0 D/D 5,833 59,787     -
   Gibbs Michael Terrence General Counsel   •       –      –    2020-02-03 4 AS $0.88 $2,889 D/D (3,283) 53,954 88%     
   Lowery Thomas J. Chief Scientific Officer   •       –      –    2020-02-03 4 AS $0.88 $6,631 D/D (7,535) 62,169 88%     
   Mcdonough John Director   –       •      –    2020-02-03 4 AS $0.88 $20,904 D/D (23,754) 489,114 88%     
   Mcdonough John Director   –       •      –    2020-01-23 4 AS $1.15 $66,030 D/D (57,417) 512,868 11%     
   Pare Anthony Chief Commercial OfficerOffice   •       –      –    2020-01-13 3 IO $0.00 $0 D/D 0 4,577 -45%     
   Mcdonough John Director   –       •      –    2020-01-08 4 OE $0.00 $0 D/D 116,666 570,285     -
   Elsbree David B Director   –       •      –    2020-01-03 4 AS $1.16 $6,167 D/D (5,316) 91,081     -
   Goldman Sachs & Co   –       –       •   2020-01-02 4 A $0.00 $0 I/I 34,188 4,270,641     -
   Jones Adrian M   –       •      –    2020-01-02 4 A $0.00 $0 I/I 34,188 4,270,641     -
   Goldman Sachs & Co   –       –       •   2020-01-02 4 A $0.00 $0 I/I 34,188 4,270,641     -
   Liebman Seymour Director   –       •      –    2020-01-01 4 OE $0.00 $0 D/D 13,289 50     -
   Elsbree David B Director   –       •      –    2020-01-01 4 OE $0.00 $0 D/D 13,289 96,397     -
   Barclay Alec SVP, Operations   •       –      –    2019-09-11 4 AS $2.92 $12,293 D/D (4,210) 42,102     -

  350 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed